Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 11 - 20 of about 103   

Articles published

CBST 98.67 +0.90 (0.92%)
price chart
Could Big Pharma's appetite for local biotechs hurt independents?
Those sounds you hear reverberating through the local biotech industry are the heavy footsteps of Big Pharma. Uncorking its plan to buy Lexington's Cubist Pharmaceuticals Inc. for $9.5 billion last week, New Jersey-based Merck & Co. became the latest ...
Related articles »  
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation ...
NEW YORK, Dec. 8, 2014 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against the Board of Directors of Cubist Pharmaceuticals Inc. ("Cubist Pharmaceuticals" or the "Company") ...
Related articles »  
Investor Alert: Cubist Pharmaceuticals Inc (NASDAQ:CBST), Applied Materials ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) was in the news recently after the stock of the company was downgraded at Jefferies from buy to hold as the analysts at Jefferies believed that the growth prospects of the company looked weak going forward.
Cubist Deal a Rare Bright Spot in Dismal Field of Antibiotics  Businessweek
Related articles »  
Tuesday Eye-Catching Stocks: Sealed Air Corporation (SEE), Cubist ...
Cubist Pharmaceuticals Inc. (CBST) of the Biotechnology sector closed out the day yesterday at $96.31, a loss of 0.00% and return on investment of 2.30% trading at a volume of 2,463,068 shares.
Investor Alert: Cubist Pharmaceuticals Inc (NASDAQ:CBST) under Investigation ...
The Shareholders Foundation announces that an investigation on behalf of investors, who currently hold shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST), was launched concerning whether the takeover of Cubist Pharmaceuticals Inc by Merck for $102 ...
Healthcare Stock News - Cubist (NASDAQ:CBST), Brookdale Senior Living ...  Techsonian (press release)
Related articles »  
Form 8-K CUBIST PHARMACEUTICALS For: Dec 19
On December 19, 2014, Cubist Pharmaceuticals, Inc. (�Cubist�, the �Company� or �we�) delivered to its executive officers and directors (collectively, the �Covered Persons�) a notice under Rule 104(b)(2)(i) of Regulation BTR, pursuant to which Cubist ...
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The ...
BALA CYNWYD, Pa., Dec. 15, 2014 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cubist Pharmaceuticals, Inc. ("Cubist Pharmaceuticals" or the "Company") ...
Related articles »  
Biotech Stocks Saw Expected Concerns: Cubist Pharmaceuticals Inc. (NASDAQ ...
Levi & Korsinsky is investigating the BOD of Cubist Pharmaceuticals Inc. (NASDAQ:CBST) [Detail Analytic Report] for potential breaches of fiduciary responsibility and further violations of state law in association with the sale of the Firm to Merck ...
Merck to Buy Antibiotics Maker for $8.4 Billion
Merck & Co. agreed to buy Cubist Pharmaceuticals Inc. for $8.4 billion as the drug giant pushes deeper into antibiotics, an area seeing renewed interest because of the rise of dangerous new infections.
Related articles »  
Healthcare Sector Movers: HCA Holdings, Inc. (HCA), Cubist Pharmaceuticals ...
In the Healthcare today HCA Holdings, Inc. (HCA) has moved with a change from open of .25% at mid-day today with a volume of 1,694,345 shares.